These evidence indicate that dysregulation of the Bmi-1/p16Ink4a pathway likely plays important roles in provoking the aging-associated decline of stem or progenitor cell function and subsequent onset of degenerative diseases. This evidence concerns the gene BMI1 and neurodegenerative disease.